# phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma

> **NIH NIH P50** · NORTHWESTERN UNIVERSITY · 2021 · $439,418


## Key facts

- **NIH application ID:** 10468354
- **Project number:** 5P50CA221747-04
- **Recipient organization:** NORTHWESTERN UNIVERSITY
- **Principal Investigator:** Atique U. Ahmed
- **Activity code:** P50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $439,418
- **Award type:** 5
- **Project period:** 2018-08-17 → 2023-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10468354

## Citation

> US National Institutes of Health, RePORTER application 10468354, phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma (5P50CA221747-04). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10468354. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*